ACT Oncology, with more than 20 years’ experience, is a biopharmaceutical development full-service, oncology specialist, providing expert, flexible and cost-effective support for North American and International development programs. Operating from headquarters in New Jersey, USA and Madrid, Spain, with regionally-based personnel throughout the USA and Europe, our dedicated team of therapeutic, scientific and analytical experts are committed to optimizing complex oncology drug research and bringing new treatments to the market rapidly and efficiently with high quality successful outcomes.
We will be in attendance at ESMO, the European Society for Medical Oncology Meeting, in Madrid-Spain, 26-30 September. Please visit us at booth number 124.
ACT Oncology offers Sponsors a wealth of experience in the management of hematology studies. We have conducted 23 programs in Multiple Myeloma, 5 in Myelodyplastic Syndrome and 5 in Lymphoma. Our strong relationships with the Multiple Myeloma Research Foundation and leading Myeloma researchers enable us to offer unparalleled support in this challenging therapeutic area.